“The Longevity Signal”
Studied for its potential role in activating telomerase, the enzyme tied to cellular aging, typically used in short, infrequent courses rather than continuously.
Epithalon is studied for its proposed effect on telomerase, the enzyme involved in maintaining telomere length, the protective caps on chromosomes that shorten with cellular aging. It's typically studied in short, cyclical courses rather than continuous use.
It's not FDA-approved and is sold as a research chemical, not a supplement or medicine.
Some human trials have been conducted, mostly out of Russia, looking at aging biomarkers, though they don't meet the scale or rigor of large Western clinical trials.
There isn't enough independently replicated human safety data to draw firm conclusions. Treat it as an early-stage research compound.
Epithalon has more human research behind it than many longevity peptides, largely from Russian research groups studying aging biomarkers, though that body of work hasn't been replicated at the scale of major Western clinical trials.
The numbers are only half of it. The Blueprint covers exact dosing per peptide, proven stacks, and step-by-step injection instructions.
The complete peptide reference. 20+ compounds broken down, step-by-step instructions, stack breakdowns, troubleshooting, and a 30% sourcing discount code.
Learn More · $40